{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T05:42:35Z","timestamp":1774849355284,"version":"3.50.1"},"reference-count":211,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T00:00:00Z","timestamp":1774828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Polycystic ovary syndrome (PCOS) is a prevalent endocrine and reproductive disorder affecting 11-13% of women worldwide. It is defined by key clinical signs like elevated androgen levels and infrequent ovulation. PCOS, the most common endocrine cause of infertility in women of reproductive age, is often linked to insulin resistance, obesity, and other metabolic issues. It is closely associated with imbalances in the metabolism of glucose and lipids. Crucially, PCOS interacts with disorders of glucose and lipid metabolism. These metabolic disorders are the main signs of PCOS and can further aggravate the condition. As a vital metabolic organ, the liver produces a range of functional secretory factors known as hepatokines, which are crucial for metabolic regulation. These hepatokines circulate and exert a \u201cDistant crosstalk\u201d effect, influencing processes like glucose uptake, fatty acid breakdown, liver glucose production, inflammation, and various other functions in peripheral tissues. A recent connection between PCOS and nonalcoholic fatty liver disease (NAFLD) has been established, with the hepato-ovarian axis hypothesis considered a possible mechanism. As a result, the liver plays a key role in PCOS and is closely linked to the metabolic disorders involving glycolipids that are often seen with the condition. This review presents an in-depth overview of hepatokines that affect PCOS and its associated glycolipid metabolic disorders, providing key insights into the hepato-ovarian axis.<\/jats:p>","DOI":"10.3389\/fendo.2026.1598164","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T04:10:43Z","timestamp":1774843843000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatokines and polycystic ovary syndrome: investigating the connection between the hepato-ovarian axis and disorders in glycolipid metabolism in PCOS: a narrative review"],"prefix":"10.3389","volume":"17","author":[{"given":"Rui","family":"Zhu","sequence":"first","affiliation":[{"name":"Department of Gynecology, Affiliated Hospital of Nanjing University of Chinese Medicine","place":["Nanjing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinzhe","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Affiliated Hospital of Nanjing University of Chinese Medicine","place":["Nanjing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingyun","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Affiliated Hospital of Nanjing University of Chinese Medicine","place":["Nanjing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuwen","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Affiliated Hospital of Nanjing University of Chinese Medicine","place":["Nanjing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yizhu","family":"Zhang","sequence":"additional","affiliation":[{"name":"School of Integrative Medicine, Nanjing University of Chinese Medicine","place":["Nanjing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Jin","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Affiliated Hospital of Nanjing University of Chinese Medicine","place":["Nanjing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huifang","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Affiliated Hospital of Nanjing University of Chinese Medicine","place":["Nanjing, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,3,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2023.07.025","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"120","author":"Teede","year":"2023","journal-title":"Fertil Steril"},{"key":"B2","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.metabol.2017.09.016","article-title":"Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences","volume":"86","author":"Anagnostis","year":"2018","journal-title":"Metabolism"},{"key":"B3","doi-asserted-by":"publisher","first-page":"16247","DOI":"10.3390\/ijms242216247","article-title":"Essential role of granulosa cell glucose and lipid metabolism on oocytes and the potential metabolic imbalance in polycystic ovary syndrome","volume":"24","author":"Zhang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B4","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s40001-023-01174-8","article-title":"Adiposity and lipid metabolism indicators mediate the adverse effect of glucose metabolism indicators on oogenesis and embryogenesis in PCOS women undergoing IVF\/ICSI cycles","volume":"28","author":"Jiang","year":"2023","journal-title":"Eur J Med Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-10-0205","article-title":"Spectrum of metabolic dysfunction in relationship with hyperandrogenemia in obese adolescent girls with polycystic ovary syndrome","volume":"162","author":"Alemzadeh","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2016.01.006","article-title":"Metabolic profile in women with polycystic ovary syndrome across adult life","volume":"65","author":"Echiburu","year":"2016","journal-title":"Metabolism"},{"key":"B7","doi-asserted-by":"publisher","first-page":"e0160571","DOI":"10.1371\/journal.pone.0160571","article-title":"To assess the association between glucose metabolism and ectopic lipid content in different clinical classifications of PCOS","volume":"11","author":"G\u00f6bl","year":"2016","journal-title":"PloS One"},{"key":"B8","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J Hepatol"},{"key":"B10","first-page":"511","article-title":"Shifting our focus from NASH to MASH","volume":"19","author":"Lichtenstein","year":"2023","journal-title":"Gastroenterol Hepatol (N Y)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12902-023-01456-6","article-title":"Hepatic steatosis in women with polycystic ovary syndrome","volume":"23","author":"Hong","year":"2023","journal-title":"BMC Endocr Disord"},{"key":"B12","doi-asserted-by":"publisher","first-page":"108783","DOI":"10.1016\/j.isci.2024.108783","article-title":"Association of metabolic-dysfunction associated steatotic liver disease with polycystic ovary syndrome","volume":"27","author":"Xu","year":"2024","journal-title":"iScience"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/S1665-2681(19)31616-3","article-title":"Prevalence of non alcoholic fatty liver disease in premenopausal, posmenopausal and polycystic ovary syndrome women","volume":"9","author":"Gutierrez-Grobe","year":"2010","journal-title":"role estrogens Ann Hepatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.2039","article-title":"Polycystic ovary syndrome is associated with nonalcoholic steatohepatitis in women of reproductive age","volume":"6","author":"Maldonado","year":"2022","journal-title":"Hepatol Commun"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab658","article-title":"Nonalcoholic fatty liver disease in women and girls with polycystic ovary syndrome","volume":"107","author":"Falzarano","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i39.14172","article-title":"Review of nonalcoholic fatty liver disease in women with polycystic ovary syndrome","volume":"20","author":"Kelley","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2017.56","article-title":"Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance","volume":"13","author":"Meex","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"B18","doi-asserted-by":"crossref","DOI":"10.1007\/s42000-023-00487-x","article-title":"Hepatokines: the missing link in the development of insulin resistance and hyperandrogenism in PCOS","volume":"22","author":"Stefanaki","year":"2023","journal-title":"Hormones (Athens)"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1097\/MOL.0000000000000290","article-title":"Regulation of lipid metabolism by angiopoietin-like proteins","volume":"27","author":"Dijk","year":"2016","journal-title":"Curr Opin Lipidol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"7197","DOI":"10.3390\/ijms21197197","article-title":"Angiopoietin-like protein 4 overexpression in visceral adipose tissue from obese subjects with impaired glucose metabolism and relationship with lipoprotein lipase","volume":"21","author":"Barchetta","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2013.11.004","article-title":"Angptl4 serves as an endogenous inhibitor of intestinal lipid digestion","volume":"3","author":"Mattijssen","year":"2013","journal-title":"Mol Metab"},{"key":"B22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.molmet.2018.03.011","article-title":"Brown adipose tissue derived ANGPTL4 controls glucose and lipid metabolism and regulates thermogenesis","volume":"11","author":"Singh","year":"2018","journal-title":"Mol Metab"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1210\/en.2005-0476","article-title":"Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism","volume":"146","author":"K\u00f6ster","year":"2005","journal-title":"Endocrinology"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-018-4583-5","article-title":"Loss of angiopoietin-like 4 (ANGPTL4) in mice with diet-induced obesity uncouples visceral obesity from glucose intolerance partly via the gut microbiota","volume":"61","author":"Janssen","year":"2018","journal-title":"Diabetologia"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2019.05.010","article-title":"ANGPTL4 in metabolic and cardiovascular disease","volume":"25","author":"Aryal","year":"2019","journal-title":"Trends Mol Med"},{"key":"B26","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1038\/s41467-018-04611-z","article-title":"Genetic inactivation of ANGPTL4 improves glucose homeostasis and is associated with reduced risk of diabetes","volume":"9","author":"Gusarova","year":"2018","journal-title":"Nat Commun"},{"key":"B27","volume-title":".Study on the role and mechanism of ANGPTL4 gene in polycystic ovary syndrome","author":"Qi","year":"2023"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2015.1068285","article-title":"Examination of angiopoietin-like protein 4, neuropeptide Y, omentin-1 levels of obese and non-obese patients with polycystic ovary syndrome","volume":"31","author":"G\u00fcne\u015f","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-1119(97)00216-3","article-title":"Structure of the gene encoding human alpha 2-HS glycoprotein (AHSG)","volume":"196","author":"Osawa","year":"1997","journal-title":"Gene"},{"key":"B30","doi-asserted-by":"publisher","first-page":"7918714","DOI":"10.1155\/2018\/7918714","article-title":"Relationship of circulating fetuin-A levels with body size and metabolic phenotypes","volume":"2018","author":"Chung","year":"2018","journal-title":"Int J Endocrinol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1210\/mend.7.11.7906861","article-title":"Serum alpha 2-HS-glycoprotein is an inhibitor of the human insulin receptor at the tyrosine kinase level","volume":"7","author":"Srinivas","year":"1993","journal-title":"Mol Endocrinol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-017-4385-1","article-title":"Metabolic crosstalk between fatty pancreas and fatty liver: effects on local inflammation and insulin secretion","volume":"60","author":"Gerst","year":"2017","journal-title":"Diabetologia"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2851","article-title":"Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance","volume":"18","author":"Pal","year":"2012","journal-title":"Nat Med"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2016.10.002","article-title":"Fetuin-A downregulates adiponectin through Wnt-PPAR\u03b3 pathway in lipid induced inflamed adipocyte","volume":"1863","author":"Agarwal","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.30499","article-title":"Fetuin-A excess expression amplifies lipid induced apoptosis and \u03b2-cell damage","volume":"237","author":"Mukhuty","year":"2022","journal-title":"J Cell Physiol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-2414","article-title":"Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose","volume":"97","author":"Ou","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2013.07.034","article-title":"Salsalate and adiponectin ameliorate hepatic steatosis by inhibition of the hepatokine fetuin-A","volume":"86","author":"Jung","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.945287","article-title":"The structure, biosynthesis, and biological roles of fetuin-A: A review","volume":"10","author":"Chekol Abebe","year":"2022","journal-title":"Front Cell Dev Biol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.4158\/EP14421.RA","article-title":"Proinflammatory and antiinflammatory attributes of fetuin-a: a novel hepatokine modulating cardiovascular and glycemic outcomes in metabolic syndrome","volume":"20","author":"Mukhopadhyay","year":"2014","journal-title":"Endocr Pract"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/b978-0-12-394317-0.00010-8","article-title":"Fetuin-A and the cardiovascular system","volume":"56","author":"Mori","year":"2012","journal-title":"Adv Clin Chem"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.3390\/jcm8122033","article-title":"Pathophysiological implication of fetuin-A glycoprotein in the development of metabolic disorders: A concise review","volume":"8","author":"Bourebaba","year":"2019","journal-title":"J Clin Med"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1159\/000362968","article-title":"Up-regulation of hepatic alpha-2-HS-glycoprotein transcription by testosterone via androgen receptor activation","volume":"33","author":"Voelkl","year":"2014","journal-title":"Cell Physiol Biochem"},{"key":"B43","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/s12902-020-0538-1","article-title":"Serum Fetuin-A levels are increased and associated with insulin resistance in women with polycystic ovary syndrome","volume":"20","author":"Liu","year":"2020","journal-title":"BMC Endocr Disord"},{"key":"B44","doi-asserted-by":"crossref","DOI":"10.1042\/bj3500589","article-title":"Fetuin-B, a second member of the fetuin family in mammals","author":"Olivier","year":"2000","journal-title":"Biochem J"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2015.09.023","article-title":"Fetuin B is a secreted hepatocyte factor linking steatosis to impaired glucose metabolism","volume":"22","author":"Meex","year":"2015","journal-title":"Cell Metab"},{"key":"B46","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1159\/000339065","article-title":"Downregulation of fetuin-B and zinc-\u03b12-glycoprotein is linked to impaired fatty acid metabolism in liver cells","volume":"30","author":"Choi","year":"2012","journal-title":"Cell Physiol Biochem"},{"key":"B47","doi-asserted-by":"publisher","first-page":"12869","DOI":"10.1038\/s41598-022-17000-w","article-title":"Hepatokine Fetuin B expression is regulated by leptin-STAT3 signalling and associated with leptin in obesity","volume":"12","author":"Wang","year":"2022","journal-title":"Sci Rep"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2018.03.023","article-title":"Fetuin-B links nonalcoholic fatty liver disease to type 2 diabetes via inducing insulin resistance: Association and path analyses","volume":"108","author":"Li","year":"2018","journal-title":"Cytokine"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00821","article-title":"TMT based proteomic analysis of human follicular fluid from overweight\/obese and normal-weight patients with polycystic ovary syndrome","volume":"10","author":"Zhang","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B50","doi-asserted-by":"publisher","first-page":"2483435","DOI":"10.1155\/2020\/2483435","article-title":"Elevated circulating fetuin-B levels are associated with insulin resistance and reduced by GLP-1RA in newly diagnosed PCOS women","volume":"2020","author":"Mokou","year":"2020","journal-title":"Mediators Inflamm"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1530\/EC-19-0243","article-title":"Increased serum fetuin-B concentration is associated with HOMA-\u03b2 and indices of liver steatosis in women with polycystic ovary syndrome: a pilot study","volume":"8","author":"Adamska","year":"2019","journal-title":"Endocr Connect"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2007.10.171","article-title":"Stimulation of selenoprotein P promoter activity in hepatoma cells by FoxO1a transcription factor","volume":"365","author":"Walter","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1002\/hep.22526","article-title":"Selenoprotein P expression is controlled through interaction of the coactivator PGC-1alpha with FoxO1a and hepatocyte nuclear factor 4alpha transcription factors","volume":"48","author":"Speckmann","year":"2008","journal-title":"Hepatology"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2010.09.015","article-title":"A liver-derived secretory protein, selenoprotein P, causes insulin resistance","volume":"12","author":"Misu","year":"2010","journal-title":"Cell Metab"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-0620","article-title":"Serum selenoprotein P levels in patients with type 2 diabetes and prediabetes: implications for insulin resistance, inflammation, and atherosclerosis","volume":"96","author":"Yang","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e34952","DOI":"10.1371\/journal.pone.0034952","article-title":"Inverse correlation between serum levels of selenoprotein P and adiponectin in patients with type 2 diabetes","volume":"7","author":"Misu","year":"2012","journal-title":"PloS One"},{"key":"B57","doi-asserted-by":"publisher","first-page":"63","DOI":"10.4093\/dmj.2013.37.1.63","article-title":"Increased selenoprotein p levels in subjects with visceral obesity and nonalcoholic Fatty liver disease","volume":"37","author":"Choi","year":"2013","journal-title":"Diabetes Metab J"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.00380.2010","article-title":"Reducing selenoprotein P expression suppresses adipocyte differentiation as a result of increased preadipocyte inflammation","volume":"300","author":"Zhang","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/oby.21841","article-title":"Circulating selenoprotein P levels in relation to MRI-derived body fat volumes, liver fat content, and metabolic disorders","volume":"25","author":"di Giuseppe","year":"2017","journal-title":"Obes (Silver Spring)"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/18.17.4633","article-title":"Impaired retinal function and vitamin A availability in mice lacking retinol-binding protein","volume":"18","author":"Quadro","year":"1999","journal-title":"EMBO J"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1038\/nature03711","article-title":"Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes","volume":"436","author":"Yang","year":"2005","journal-title":"Nature"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-2745","article-title":"Retinol-binding protein 4 and its relation to insulin resistance in obese children before and after weight loss","volume":"93","author":"Reinehr","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-0360","article-title":"Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes","volume":"29","author":"Cho","year":"2006","journal-title":"Diabetes Care"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.2337\/dc06-2034","article-title":"Circulating retinol-binding protein-4, insulin sensitivity, insulin secretion, and insulin disposition index in obese and nonobese subjects","volume":"30","author":"Broch","year":"2007","journal-title":"Diabetes Care"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2014.01.018","article-title":"RBP4 activates antigen-presenting cells, leading to adipose tissue inflammation and systemic insulin resistance","volume":"19","author":"Moraes-Vieira","year":"2014","journal-title":"Cell Metab"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054862","article-title":"Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects","volume":"354","author":"Graham","year":"2006","journal-title":"N Engl J Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1219","article-title":"Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people","volume":"92","author":"Qi","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2013877117","article-title":"Retinol binding protein 4 primes the NLRP3 inflammasome by signaling through Toll-like receptors 2 and 4","volume":"117","author":"Moraes-Vieira","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2009.01.004","article-title":"Non-alcoholic fatty liver disease pathogenesis: the present and the future","volume":"41","author":"Petta","year":"2009","journal-title":"Dig Liver Dis"},{"key":"B70","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.freeradbiomed.2022.12.085","article-title":"Exosomal RBP4 potentiated hepatic lipid accumulation and inflammation in high-fat-diet-fed mice by promoting M1 polarization of Kupffer cells","volume":"195","author":"Yao","year":"2023","journal-title":"Free Radic Biol Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-006-0006-3","article-title":"Elevated serum RBP4 is associated with insulin resistance in women with polycystic ovary syndrome","volume":"30","author":"Weiping","year":"2006","journal-title":"Endocrine"},{"key":"B72","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ejogrb.2012.01.026","article-title":"Are plasma levels of visfatin and retinol-binding protein 4 (RBP4) associated with body mass, metabolic and hormonal disturbances in women with polycystic ovary syndrome","volume":"162","author":"Olszanecka-Glinianowicz","year":"2012","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2008.10.011","article-title":"Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism","volume":"8","author":"Kumar","year":"2008","journal-title":"Cell Metab"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.931782","article-title":"Adropin is a novel regulator of endothelial function","volume":"122","author":"Lovren","year":"2010","journal-title":"Circulation"},{"key":"B75","doi-asserted-by":"publisher","first-page":"101068","DOI":"10.1016\/j.redox.2018.101068","article-title":"Adropin protects against liver injury in nonalcoholic steatohepatitis via the Nrf2 mediated antioxidant capacity","volume":"21","author":"Chen","year":"2019","journal-title":"Redox Biol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1530\/JOE-20-0077","article-title":"Adropin inhibited tilapia hepatic glucose output and triglyceride accumulation via AMPK activation","volume":"246","author":"Zhang","year":"2020","journal-title":"J Endocrinol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ18-0060","article-title":"Serum adropin levels are decreased in Chinese type 2 diabetic patients and negatively correlated with body mass index","volume":"65","author":"Zang","year":"2018","journal-title":"Endocr J"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.15430\/JCP.2018.23.4.191","article-title":"Plasma adropin as a potential marker predicting obesity and obesity-associated cancer in korean patients with type 2 diabetes mellitus","volume":"23","author":"Choi","year":"2018","journal-title":"J Cancer Prev"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-016-0453-5","article-title":"A possible connection between tumor necrosis factor alpha and adropin levels in polycystic ovary syndrome","volume":"39","author":"Kume","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2017.1379498","article-title":"Adropin levels in women with polycystic ovaries undergoing ovarian stimulation: correlation with lipoprotein lipid profiles","volume":"34","author":"Bousmpoula","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2021.01.020","article-title":"Potential effects of adropin on systemic metabolic and hormonal abnormalities in polycystic ovary syndrome","volume":"42","author":"Ye","year":"2021","journal-title":"Reprod BioMed Online"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/iub.1709","article-title":"Significance of circulatory DPP4 activity in metabolic diseases","volume":"70","author":"Nargis","year":"2018","journal-title":"IUBMB Life"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1007\/s13300-011-0002-3","article-title":"Incretin-based therapy: a powerful and promising weapon in the treatment of type 2 diabetes mellitus","volume":"2","author":"Koliaki","year":"2011","journal-title":"Diabetes Ther"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-0496","article-title":"Adipose dipeptidyl peptidase-4 and obesity: correlation with insulin resistance and depot-specific release from adipose tissue in vivo and in vitro","volume":"36","author":"Sell","year":"2013","journal-title":"Diabetes Care"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab078","article-title":"DPP4 activity, hyperinsulinemia, and atherosclerosis","volume":"106","author":"Love","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2017.02.071","article-title":"Dipeptidyl peptidase-4 impairs insulin signaling and promotes lipid accumulation in hepatocytes","volume":"485","author":"Rufinatscha","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13444","article-title":"Dipeptidyl peptidase 4 serum activity and concentration are increased in women with polycystic ovary syndrome","volume":"87","author":"Blauschmidt","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B88","doi-asserted-by":"publisher","first-page":"bqac030","DOI":"10.1210\/endocr\/bqac030","article-title":"Deletion of gdf15 reduces ER stress-induced beta-cell apoptosis and diabetes","volume":"163","author":"Xu","year":"2022","journal-title":"Endocrinology"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.112.150656","article-title":"Cardiokines: recent progress in elucidating the cardiac secretome","volume":"126","author":"Shimano","year":"2012","journal-title":"Circulation"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/ijo.2014.27","article-title":"NAG-1\/GDF-15 prevents obesity by increasing thermogenesis, lipolysis and oxidative metabolism","volume":"38","author":"Chrysovergis","year":"2014","journal-title":"Int J Obes (Lond)"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-024-02335-9","article-title":"Hepatokines: unveiling the molecular and cellular mechanisms connecting hepatic tissue to insulin resistance and inflammation","volume":"61","author":"Miao","year":"2024","journal-title":"Acta Diabetol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-023-03377-9","article-title":"Growth differentiation factor 15 (GDF-15) in endocrinology","volume":"81","author":"Iglesias","year":"2023","journal-title":"Endocrine"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2016.1138459","article-title":"IGF-1 and IGFBP-1 in peripheral blood and decidua of early miscarriages with euploid embryos: comparison between women with and without PCOS","volume":"32","author":"Luo","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12967-015-0762-z","article-title":"Insulin-like growth factor-1 deficiency and metabolic syndrome","volume":"14","author":"Aguirre","year":"2016","journal-title":"J Transl Med"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.2001.280.5.E745","article-title":"Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance","volume":"280","author":"Kern","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B96","doi-asserted-by":"publisher","first-page":"e217","DOI":"10.1038\/ctg.2016.72","article-title":"The association between IGF-1 levels and the histologic severity of nonalcoholic fatty liver disease","volume":"8","author":"Dichtel","year":"2017","journal-title":"Clin Transl Gastroenterol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.tem.2015.11.009","article-title":"Endothelial IGF-1 receptor signalling in diabetes and insulin resistance","volume":"27","author":"Cubbon","year":"2016","journal-title":"Trends Endocrinol Metab"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.4103\/0974-1208.117171","article-title":"Follicular fluid insulin like growth factor-1 (FF IGF-1) is a biochemical marker of embryo quality and implantation rates in in vitro fertilization cycles","volume":"6","author":"Mehta","year":"2013","journal-title":"J Hum Reprod Sci"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-1378","article-title":"Role of Insulin-like growth factors in initiation of follicle growth in normal and polycystic human ovaries","volume":"98","author":"Stubbs","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00777","article-title":"Growth hormone and insulin-like growth factor action in reproductive tissues","volume":"10","author":"Ipsa","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.17772\/gp\/60708","article-title":"Insulin-like growth factor-1 isoforms in human ovary","volume":"86","author":"Brazert","year":"2015","journal-title":"Preliminary Rep Expression IGF-1 Gene PCOS patients healthy controls Ginekol Pol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"719050","DOI":"10.1155\/2014\/719050","article-title":"Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth","volume":"2014","author":"Rojas","year":"2014","journal-title":"Int J Reprod Med"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1159\/000529354","article-title":"Elevated insulin-like growth factor-1-induced female rats perpetuate the polycystic ovary syndrome phenotype: pathological mechanism of insulin-like growth factor-1 in polycystic ovary syndrome","volume":"88","author":"Fu","year":"2023","journal-title":"Gynecol Obstet Invest"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.2415","article-title":"Plasma follistatin is elevated in patients with type 2 diabetes: relationship to hyperglycemia, hyperinsulinemia, and systemic low-grade inflammation","volume":"29","author":"Hansen","year":"2013","journal-title":"Diabetes Metab Res Rev"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-3668","article-title":"Circulating follistatin is liver-derived and regulated by the glucagon-to-insulin ratio","volume":"101","author":"Hansen","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-2005","article-title":"Role of follistatin in promoting adipogenesis in women","volume":"94","author":"Flanagan","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"B107","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1038\/s41591-018-0129-0","article-title":"Inactivating hepatic follistatin alleviates hyperglycemia","volume":"24","author":"Tao","year":"2018"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2009.06.009","article-title":"The relationship between follistatin and chronic low-grade inflammation in women with polycystic ovary syndrome","volume":"92","author":"Chen","year":"2009","journal-title":"Fertil Steril"},{"key":"B109","doi-asserted-by":"publisher","first-page":"e0246200","DOI":"10.1371\/journal.pone.0246200","article-title":"Circulating resistin and follistatin levels in obese and non-obese women with polycystic ovary syndrome: A systematic review and meta-analysis","volume":"16","author":"Raeisi","year":"2021","journal-title":"PloS One"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1314123","article-title":"Interorgan communication with the liver: novel mechanisms and therapeutic targets","volume":"14","author":"Zhao","year":"2023","journal-title":"Front Immunol"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0131-0","article-title":"The IRE1\u03b1-XBP1s pathway promotes insulin-stimulated glucose uptake in adipocytes by increasing PPAR\u03b3 activity","volume":"50","author":"Cho","year":"2018","journal-title":"Exp Mol Med"},{"key":"B112","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3892\/br.2017.890","article-title":"Metabolic role of fibroblast growth factor 21 in liver, adipose and nervous system tissues","volume":"6","author":"Lin","year":"2017","journal-title":"BioMed Rep"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2018.12.003","article-title":"Hepatic c-Jun regulates glucose metabolism via FGF21 and modulates body temperature through the neural signals","volume":"20","author":"Xiao","year":"2019","journal-title":"Mol Metab"},{"key":"B114","doi-asserted-by":"publisher","first-page":"153994","DOI":"10.1016\/j.metabol.2019.153994","article-title":"Fibroblast growth factor 21 in non-alcoholic fatty liver disease","volume":"101","author":"Tucker","year":"2019","journal-title":"Metabolism"},{"key":"B115","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.cmet.2020.06.008","article-title":"FGF21 signals to glutamatergic neurons in the ventromedial hypothalamus to suppress carbohydrate intake","volume":"32","author":"Jensen-Cody","year":"2020","journal-title":"Cell Metab"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.2337\/db14-0541","article-title":"FGF21 maintains glucose homeostasis by mediating the cross talk between liver and brain during prolonged fasting","volume":"63","author":"Liang","year":"2014","journal-title":"Diabetes"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2011.05.003","article-title":"The link between fibroblast growth factor 21 and sterol regulatory element binding protein 1c during lipogenesis in hepatocytes","volume":"342","author":"Zhang","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1210\/en.2009-0532","article-title":"Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis","volume":"150","author":"Badman","year":"2009","journal-title":"Endocrinology"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2017.12.008","article-title":"Hepatic regulation of VLDL receptor by PPAR\u03b2\/\u03b4 and FGF21 modulates non-alcoholic fatty liver disease","volume":"8","author":"Zarei","year":"2018","journal-title":"Mol Metab"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-016-2774-2","article-title":"FGF21 ameliorates nonalcoholic fatty liver disease by inducing autophagy","volume":"420","author":"Zhu","year":"2016","journal-title":"Mol Cell Biochem"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2014.07.012","article-title":"FGF21 acts centrally to induce sympathetic nerve activity, energy expenditure, and weight loss","volume":"20","author":"Owen","year":"2014","journal-title":"Cell Metab"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1101\/gad.177857.111","article-title":"FGF21 regulates PGC-1\u03b1 and browning of white adipose tissues in adaptive thermogenesis","volume":"26","author":"Fisher","year":"2012","journal-title":"Genes Dev"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2016.05.026","article-title":"Fibroblast growth factor 21 (FGF21) inhibits macrophage-mediated inflammation by activating Nrf2 and suppressing the NF-\u03baB signaling pathway","volume":"38","author":"Yu","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14383","article-title":"A long-acting FGF21 alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis partly through an FGF21-adiponectin-IL17A pathway","volume":"175","author":"Bao","year":"2018","journal-title":"Br J Pharmacol"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-015-2358-6","article-title":"Fibroblast growth factor (FGF21) protects mouse liver against D-galactose-induced oxidative stress and apoptosis via activating Nrf2 and PI3K\/Akt pathways","volume":"403","author":"Yu","year":"2015","journal-title":"Mol Cell Biochem"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1006962107","article-title":"Fibroblast growth factor 21 regulates energy metabolism by activating the AMPK-SIRT1-PGC-1alpha pathway","volume":"107","author":"Chau","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M114.565960","article-title":"Fibroblast growth factor 21 is regulated by the IRE1\u03b1-XBP1 branch of the unfolded protein response and counteracts endoplasmic reticulum stress-induced hepatic steatosis","volume":"289","author":"Jiang","year":"2014","journal-title":"J Biol Chem"},{"key":"B128","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.taap.2015.11.012","article-title":"Fibroblast growth factor 21 attenuates hepatic fibrogenesis through TGF-\u03b2\/smad2\/3 and NF-\u03baB signaling pathways","volume":"290","author":"Xu","year":"2016","journal-title":"Toxicol Appl Pharmacol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-021-06707-0","article-title":"FGF21 ameliorates hepatic fibrosis by multiple mechanisms","volume":"48","author":"Meng","year":"2021","journal-title":"Mol Biol Rep"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3250","article-title":"FGF21 contributes to neuroendocrine control of female reproduction","volume":"19","author":"Owen","year":"2013","journal-title":"Nat Med"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1007\/s11011-015-9789-3","article-title":"Potential roles of fibroblast growth factor 21 in the brain","volume":"31","author":"Sa-Nguanmoo","year":"2016","journal-title":"Metab Brain Dis"},{"key":"B132","doi-asserted-by":"publisher","first-page":"e195","DOI":"10.1002\/ctm2.195","article-title":"Time-restricted feeding improves the reproductive function of female mice via liver fibroblast growth factor 21","volume":"10","author":"Hua","year":"2020","journal-title":"Clin Transl Med"},{"key":"B133","doi-asserted-by":"publisher","first-page":"155188","DOI":"10.1016\/j.cyto.2020.155188","article-title":"Serum \u03b2-Klotho concentrations are increased in women with polycystic ovary syndrome","volume":"134","author":"Bednarska","year":"2020","journal-title":"Cytokine"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2021.07.1203","article-title":"Oxidative stress promotes hyperandrogenism by reducing sex hormone-binding globulin in polycystic ovary syndrome","volume":"116","author":"Sun","year":"2021","journal-title":"Fertil Steril"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1530\/EC-20-0401","article-title":"The hepatic lipidome and HNF4\u03b1 and SHBG expression in human liver","volume":"9","author":"Winters","year":"2020","journal-title":"Endocr Connect"},{"key":"B136","doi-asserted-by":"publisher","first-page":"113261","DOI":"10.1016\/j.biopha.2022.113261","article-title":"Sex hormone binding globulin as a potential drug candidate for liver-related metabolic disorders treatment","volume":"153","author":"Bourebaba","year":"2022","journal-title":"BioMed Pharmacother"},{"key":"B137","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2147\/IJWH.S344542","article-title":"Effect of sex hormone-binding globulin on polycystic ovary syndrome: mechanisms, manifestations, genetics, and treatment","volume":"14","author":"Xing","year":"2022","journal-title":"Int J Womens Health"},{"key":"B138","doi-asserted-by":"publisher","first-page":"7624932","DOI":"10.1155\/2018\/7624932","article-title":"Genetic variants associated with hyperandrogenemia in PCOS pathophysiology","volume":"2018","author":"Dadachanji","year":"2018","journal-title":"Genet Res Int"},{"key":"B139","doi-asserted-by":"publisher","first-page":"8191","DOI":"10.3390\/ijms21218191","article-title":"Sex hormone-binding globulin (SHBG) as an early biomarker and therapeutic target in polycystic ovary syndrome","volume":"21","author":"Qu","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0804381","article-title":"Sex hormone-binding globulin and risk of type 2 diabetes in women and men","volume":"361","author":"Ding","year":"2009","journal-title":"N Engl J Med"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.2337\/diab.40.1.123","article-title":"Low sex-hormone-binding globulin concentration as independent risk factor for development of NIDDM. 12-yr follow-up of population study of women in Gothenburg, Sweden","volume":"40","author":"Lindstedt","year":"1991","journal-title":"Diabetes"},{"key":"B142","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.tem.2011.09.005","article-title":"Sex hormone-binding globulin and type 2 diabetes mellitus","volume":"23","author":"Le","year":"2012","journal-title":"Trends Endocrinol Metab"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.2337\/db10-0179","article-title":"Relationships of circulating sex hormone-binding globulin with metabolic traits in humans","volume":"59","author":"Peter","year":"2010","journal-title":"Diabetes"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1530\/EC-19-0044","article-title":"Does sex hormone-binding globulin cause insulin resistance during pubertal growth","volume":"8","author":"Le","year":"2019","journal-title":"Endocr Connect"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M512636200","article-title":"Partnership of PGC-1alpha and HNF4alpha in the regulation of lipoprotein metabolism","volume":"281","author":"Rhee","year":"2006","journal-title":"J Biol Chem"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.2337\/db06-0035","article-title":"Common hepatic nuclear factor-4alpha variants are associated with high serum lipid levels and the metabolic syndrome","volume":"55","author":"Weissglas-Volkov","year":"2006","journal-title":"Diabetes"},{"key":"B147","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s10528-011-9472-2","article-title":"Association of hepatocyte nuclear factor 4 alpha polymorphisms with type 2 diabetes with or without metabolic syndrome in Malaysia","volume":"50","author":"Saif-Ali","year":"2012","journal-title":"Biochem Genet"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2017.1411474","article-title":"SHBG expression is correlated with PI3K\/AKT pathway activity in a cellular model of human insulin resistance","volume":"34","author":"Feng","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1002\/oby.20077","article-title":"Liver fat and SHBG affect insulin resistance in midlife women: the Study of Women\u2019s Health Across the Nation (SWAN)","volume":"21","author":"Kavanagh","year":"2013","journal-title":"Obes (Silver Spring)"},{"key":"B150","doi-asserted-by":"publisher","first-page":"3062319","DOI":"10.1155\/2018\/3062319","article-title":"Protective effect of sex hormone-binding globulin against metabolic syndrome: in vitro evidence showing anti-inflammatory and lipolytic effects on adipocytes and macrophages","volume":"2018","author":"Yamazaki","year":"2018","journal-title":"Mediators Inflamm"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/del175","article-title":"Low sex hormone-binding globulin is associated with low high-density lipoprotein cholesterol and metabolic syndrome in women with PCOS","volume":"21","author":"Chen","year":"2006","journal-title":"Hum Reprod"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2019.09.010","article-title":"Sex hormone-binding globulin and polycystic ovary syndrome","volume":"499","author":"Zhu","year":"2019","journal-title":"Clin Chim Acta"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.51.34105","article-title":"Hepatocyte nuclear factor-4 controls transcription from a TATA-less human sex hormone-binding globulin gene promoter","volume":"273","author":"J\u00e4nne","year":"1998","journal-title":"J Biol Chem"},{"key":"B154","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s13287-019-1260-7","article-title":"Mesenchymal stem cells overexpressing hepatocyte nuclear factor-4 alpha alleviate liver injury by modulating anti-inflammatory functions in mice","volume":"10","author":"Ye","year":"2019","journal-title":"Stem Cell Res Ther"},{"key":"B155","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s12276-020-00551-1","article-title":"Hepatocyte nuclear factor 4\u03b1 and cancer-related cell signaling pathways: a promising insight into cancer treatment","volume":"53","author":"Lv","year":"2021","journal-title":"Exp Mol Med"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1210\/me.2012-1152","article-title":"IL1\u03b2 down-regulation of sex hormone-binding globulin production by decreasing HNF-4\u03b1 via MEK-1\/2 and JNK MAPK pathways","volume":"26","author":"Sim\u00f3","year":"2012","journal-title":"Mol Endocrinol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1210\/en.2016-1668","article-title":"Sex hormone-binding globulin reduction in metabolic disorders may play a role in NAFLD development","volume":"158","author":"Saez-Lopez","year":"2017","journal-title":"Endocrinology"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2017.07.015","article-title":"Prevention of type 2 diabetes mellitus in polycystic ovary syndrome: A review","author":"Anwar","year":"2017","journal-title":"Diabetes Metab Syndr"},{"key":"B159","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.3390\/children9111748","article-title":"Sex hormone-binding globulin (SHBG) reduction: the alarm bell for the risk of non-alcoholic fatty liver disease in adolescents with polycystic ovary syndrome","volume":"9","author":"Urbano","year":"2022","journal-title":"Children (Basel)"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.9.2734","article-title":"Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein","volume":"51","author":"Nishizawa","year":"2002","journal-title":"Diabetes"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1530\/REP-14-0435","article-title":"Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome","volume":"149","author":"Spritzer","year":"2015","journal-title":"Reproduction"},{"key":"B162","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.mce.2012.10.010","article-title":"Adipocyte biology in polycystic ovary syndrome","volume":"373","author":"Barber","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1290","article-title":"Adipose tissue has aberrant morphology and function in PCOS: enlarged adipocytes and low serum adiponectin, but not circulating sex steroids, are strongly associated with insulin resistance","volume":"96","author":"Manner\u00e5s-Holm","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13808","article-title":"Inter-related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in PCOS","volume":"89","author":"Shorakae","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2020.10.003","article-title":"Association between human SHBG gene polymorphisms and risk of PCOS: a meta-analysis","volume":"42","author":"Li","year":"2021","journal-title":"Reprod BioMed Online"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.741285","article-title":"The association of CYP17A1, CYP19A1, and SHBG gene polymorphisms in polycystic ovary syndrome susceptibility: A systematic review and meta-analysis","volume":"13","author":"Xing","year":"2022","journal-title":"Front Physiol"},{"key":"B167","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/19396368.2017.1410591","article-title":"Sex hormone binding globulin - an important biomarker for predicting PCOS risk: A systematic review and meta-analysis","volume":"64","author":"Deswal","year":"2018","journal-title":"Syst Biol Reprod Med"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200318921","article-title":"C-reactive protein: a critical update","volume":"111","author":"Pepys","year":"2003","journal-title":"J Clin Invest"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350824","article-title":"C-reactive protein levels as a direct indicator of interleukin-6 levels in humans in vivo","volume":"35","author":"Bataille","year":"1992","journal-title":"Arthritis Rheumatol"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9150(99)00463-3","article-title":"Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link","volume":"148","author":"Yudkin","year":"2000","journal-title":"Atherosclerosis"},{"key":"B171","volume-title":"The changes of C-reactive protein and adiponectin in different stages of glycometabolism and different numbers of components of metabolic syndrome","author":"Dongmei","year":"2007"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.28.10.2497","article-title":"Elevated C-reactive protein is a predictor of the development of diabetes in a general Japanese population: the Hisayama Study","volume":"28","author":"Doi","year":"2005","journal-title":"Diabetes Care"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.5604\/12321966.1226842","article-title":"Cardiovascular system diseases in patients with polycystic ovary syndrome - the role of inflammation process in this pathology and possibility of early diagnosis and prevention","volume":"23","author":"Marciniak","year":"2016","journal-title":"Ann Agric Environ Med"},{"key":"B174","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s125-002-8256-1","article-title":"Subclinical inflammation in newly detected Type II diabetes and impaired glucose tolerance","volume":"45","author":"Temelkova-Kurktschiev","year":"2002","journal-title":"Diabetologia"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.102.1.42","article-title":"Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS)","volume":"102","author":"Festa","year":"2000","journal-title":"Circulation"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.51.4.1131","article-title":"Insulin Resistance Atherosclerosis Study. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study","volume":"51","author":"Festa","year":"2002","journal-title":"Diabetes"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.22.12.1971","article-title":"Body mass index, diabetes, and C-reactive protein among U.S. adults","volume":"22","author":"Ford","year":"1999","journal-title":"Diabetes Care"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2012.04.005","article-title":"Arsenite activates NF\u03baB through induction of C-reactive protein","volume":"261","author":"Druwe","year":"2012","journal-title":"Toxicol Appl Pharmacol"},{"key":"B179","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1152\/nips.01369.2001","article-title":"Plasminogen activator inhibitor 1: physiological and pathophysiological roles","volume":"17","author":"Binder","year":"2002","journal-title":"News Physiol Sci"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfi272","article-title":"Rho\/Rho-kinase and C-reactive protein relationship in hypertension and atherosclerosis","volume":"21","author":"Cal\u00f2","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-006-0522-y","article-title":"C-reactive protein induces phosphorylation of insulin receptor substrate-1 on Ser307 and Ser 612 in L6 myocytes, thereby impairing the insulin signalling pathway that promotes glucose transport","volume":"50","author":"D\u2019Alessandris","year":"2007","journal-title":"Diabetologia"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1038\/nm1372","article-title":"Induction of leptin resistance through direct interaction of C-reactive protein with leptin","volume":"12","author":"Chen","year":"2006","journal-title":"Nat Med"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvr088","article-title":"Human C-reactive protein exacerbates metabolic disorders in association with adipose tissue remodelling","volume":"91","author":"Kaneko","year":"2011","journal-title":"Cardiovasc Res"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1210\/me.2006-0354","article-title":"C-reactive protein suppresses insulin signaling in endothelial cells: role of spleen tyrosine kinase","volume":"21","author":"Xu","year":"2007","journal-title":"Mol Endocrinol"},{"key":"B185","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2007.03.003","article-title":"C-reactive protein induces endothelial cell apoptosis and matrix metalloproteinase-9 production in human mononuclear cells: Implications for the destabilization of atherosclerotic plaque","volume":"196","author":"Nabata","year":"2008","journal-title":"Atherosclerosis"},{"key":"B186","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.169.12.7019","article-title":"C-reactive protein mediates protection from lipopolysaccharide through interactions with Fc gamma R","volume":"169","author":"Mold","year":"2002","journal-title":"J Immunol"},{"key":"B187","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1016\/S0168-8227(03)00122-0","article-title":"Pre-diabetes, insulin resistance, inflammation and CVD risk","author":"Haffner","year":"2003","journal-title":"Diabetes Res Clin Pract"},{"key":"B188","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M209649200","article-title":"Scavenger receptors class A-I\/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages","volume":"277","author":"Kunjathoor","year":"2002","journal-title":"J Biol Chem"},{"key":"B189","doi-asserted-by":"publisher","DOI":"10.1172\/JCI37385","article-title":"Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight\/obese humans","volume":"119","author":"Stanhope","year":"2009","journal-title":"J Clin Invest"},{"key":"B190","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.amjcard.2010.02.017","article-title":"Relation of C-reactive protein to abdominal adiposity","volume":"106","author":"Brooks","year":"2010","journal-title":"Am J Cardiol"},{"key":"B191","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1172\/JCI200317797","article-title":"The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice","volume":"112","author":"Xu","year":"2003","journal-title":"J Clin Invest"},{"key":"B192","volume-title":"Role of C-reactiive protein in metabolic syndrome","author":"Hai","year":"2005"},{"key":"B193","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(98)00093-X","article-title":"Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease","volume":"31","author":"Mehta","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"B194","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0802260","article-title":"The metabolic syndrome is associated with elevated circulating C-reactive protein in healthy reference range, a systemic low-grade inflammatory state","volume":"27","author":"Tamakoshi","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"key":"B195","doi-asserted-by":"publisher","first-page":"762","DOI":"10.3390\/biomedicines9070762","article-title":"Role of leptin in non-alcoholic fatty liver disease","volume":"9","author":"Jim\u00e9nez-Cortegana","year":"2021","journal-title":"Biomedicines"},{"key":"B196","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.metabol.2014.10.012","article-title":"Leptin in nonalcoholic fatty liver disease: A narrative review","volume":"64","author":"Polyzos","year":"2015","journal-title":"Metabolism"},{"key":"B197","doi-asserted-by":"publisher","first-page":"26740","DOI":"10.1038\/srep26740","article-title":"C-reactive protein promotes diabetic kidney disease in db\/db mice via the CD32b-Smad3-mTOR signaling pathway","volume":"6","author":"You","year":"2016","journal-title":"Sci Rep"},{"key":"B198","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12979-022-00322-8","article-title":"Association of leukocyte mitochondrial DNA copy number with longitudinal C-reactive protein levels and survival in older adults: A cohort study","volume":"19","author":"Wu","year":"2022","journal-title":"Immun Ageing"},{"key":"B199","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.17233","article-title":"Radiation-induced C-reactive protein triggers apoptosis of vascular smooth muscle cells through ROS interfering with the STAT3\/Ref-1 complex","volume":"26","author":"Ryu","year":"2022","journal-title":"J Cell Mol Med"},{"key":"B200","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.3390\/antiox10121917","article-title":"ROS-Induced mtDNA Release: The Emerging Messenger for Communication between Neurons and Innate Immune Cells during Neurodegenerative Disorder Progression","volume":"10","author":"Zhao","year":"2021","journal-title":"Antioxidants"},{"key":"B201","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1080\/17461391.2019.1571114","article-title":"Mechanisms of beneficial effects of exercise training on non-alcoholic fatty liver disease (NAFLD): Roles of oxidative stress and inflammation","volume":"19","author":"Farzanegi","year":"2019","journal-title":"Eur J Sport Sci"},{"key":"B202","doi-asserted-by":"publisher","first-page":"e8183","DOI":"10.1097\/MD.0000000000008183","article-title":"Effects of metformin treatment on serum levels of C-reactive protein and interleukin-6 in women with polycystic ovary syndrome: a meta-analysis: A PRISMA-compliant article","volume":"96","author":"Wang","year":"2017","journal-title":"Med (Baltimore)"},{"key":"B203","article-title":"Subacute inflammatory reaction in follicular fluid of Chinese PCOS patients","volume":"31","author":"Xing","year":"2015","journal-title":"Chin J Pathophysiol"},{"key":"B204","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/1472-6874-14-93","article-title":"Effect of metformin on serum interleukin-6 levels in polycystic ovary syndrome: a systematic review","volume":"14","author":"Xu","year":"2014","journal-title":"BMC Womens Health"},{"key":"B205","doi-asserted-by":"publisher","DOI":"10.22038\/IJBMS.2017.24801.6167","article-title":"Evaluation of TNF-\u03b1 and IL-6 mRNAs expressions in visceral and subcutaneous adipose tissues of polycystic ovarian rats and effects of resveratrol","volume":"21","author":"Ghowsi","year":"2018","journal-title":"Iran J Basic Med Sci"},{"key":"B206","volume-title":"Signifiance and changes of serum C-reactiveprotein,visfatin and chemerin levels in patients with polycystic ovarian sydrome","author":"Ying","year":"2012"},{"key":"B207","doi-asserted-by":"publisher","DOI":"10.3109\/09513590.2012.683082","article-title":"Mediators of chronic inflammation in polycystic ovarian syndrome","volume":"28","author":"Deligeoroglou","year":"2012","journal-title":"Gynecol Endocrinol"},{"key":"B208","doi-asserted-by":"publisher","DOI":"10.1016\/j.steroids.2011.12.003","article-title":"Inflammation in Polycystic Ovary Syndrome: underpinning of insulin resistance and ovarian dysfunction","volume":"77","author":"Gonz\u00e1lez","year":"2012","journal-title":"Steroids"},{"key":"B209","doi-asserted-by":"publisher","DOI":"10.1097\/01.mnh.0000214775.42103.a5","article-title":"From big fat cells to high blood pressure: a pathway to obesity-associated hypertension","volume":"15","author":"Pausova","year":"2006","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B210","first-page":"319A","article-title":"Oxidative stress induces expression of CYP11A, CYP17, STAR and 3bHSD in rat theca-interstitial cells","volume":"12","author":"Piotrowski","year":"2005","journal-title":"J Soc Gynecol Invest"},{"key":"B211","doi-asserted-by":"publisher","DOI":"10.1095\/biolreprod61.4.993","article-title":"Tumor necrosis factor-alpha stimulates proliferation of rat ovarian theca-interstitial cells","volume":"61","author":"Spaczynski","year":"1999","journal-title":"Biol Reprod"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1598164\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T04:10:56Z","timestamp":1774843856000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1598164\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,30]]},"references-count":211,"alternative-id":["10.3389\/fendo.2026.1598164"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1598164","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,30]]},"article-number":"1598164"}}